« Previous
Next »
Journal of Hepatology
Volume 50, Issue 6
, Pages
1258-1266
, June 2009
Signalling pathways in alcohol-induced liver inflammation
-
Cells involved in alcoholic liver injury. Alcohol-mediated increase in gut-derived endotoxin with oxidative stress mechanisms sensitizes hepatic macrophages to release inflammatory cytokines such as T
Cells involved in alcoholic liver injury. Alcohol-mediated increase in gut-derived endotoxin with oxidative stress mechanisms sensitizes hepatic macrophages to release inflammatory cytokines such as TNFα, IL-1β, IL-1α and IL-6 that affects stellate cells and hepatocyte functions. Endotoxin also affects stellate cell and endothelial cell activation and contributes to liver injury.
-
TLR4 mediated signalling in alcohol-exposed macrophages. Alcohol alters functions of Toll-like receptors TLR4 in the liver resulting in regulation of MyD88 dependent activation of downstream signallinTLR4 mediated signalling in alcohol-exposed macrophages. Alcohol alters functions of Toll-like receptors TLR4 in the liver resulting in regulation of MyD88 dependent activation of downstream signalling molecules such as IRAK kinase, IKK and NFκB. MyD88-independent, TRIF-dependent activation of IRF3 is also regulated alcohol exposure. Alcohol also induces NADPH oxidase via reactive oxygen species leading to inflammation.
-
TLR4 mediated alcohol-exposed macrophages signalling in alcohol-exposed macrophages. Alcohol alters functions of Toll-like receptors TLR4 in the liver resulting in activation of MAP kinases culminatinTLR4 mediated alcohol-exposed macrophages signalling in alcohol-exposed macrophages. Alcohol alters functions of Toll-like receptors TLR4 in the liver resulting in activation of MAP kinases culminating in alteration of binding to transcription factors such as Egr-1, AP-1 and STAT1. Alcohol also affects cytokine mRNA stability via modulation of MAP kinase activity.
☆ The underlying research reported in the study was funded by the NIH Institutes of Health, NIH AA017357 and AA015283 conference grant. The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.
PII: S0168-8278(09)00168-8
doi: 10.1016/j.jhep.2009.03.007
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 50, Issue 6
, Pages
1258-1266
, June 2009
